Lupus anticoagulant inhibition of in Vitro prostacyclin release is associated with a thrombosis-prone subset of patients
- 31 January 1991
- journal article
- research article
- Published by Elsevier in The American Journal of Medicine
- Vol. 90 (1) , 47-53
- https://doi.org/10.1016/0002-9343(91)90505-r
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Immunological specificity and mechanism of action of IgG lupus anticoagulantsBlood, 1987
- Prostacyclin in systemic lupus and anticardiolipin syndrome.Annals of the Rheumatic Diseases, 1987
- LUPUS ANTICOAGULANT, RECURRENT ABORTION, AND PROSTACYCLIN PRODUCTION BY CULTURED SMOOTH MUSCLE CELLSThe Lancet, 1983
- ANTICARDIOLIPIN ANTIBODIES: DETECTION BY RADIOIMMUNOASSAY AND ASSOCIATION WITH THROMBOSIS IN SYSTEMIC LUPUS ERYTHEMATOSUSThe Lancet, 1983
- Deficiency of a plasma factor stimulating vascular prostacyclin generation in patients with lupus nephritis and glomerular thrombi and its correction by ancrod: In-vivo and in-vitro observationsThrombosis Research, 1982
- “Lupus” Anticoagulant and Thrombosis – Possible Role of Inhibition of Prostacyclin FormationThrombosis and Haemostasis, 1982
- ARTERIAL THROMBOSIS, INTRAUTERINE DEATH AND "LUPUS" ANTICOAGULANT: DETECTION OF IMMUNOGLOBULIN INTERFERING WITH PROSTACYCLIN FORMATIONThe Lancet, 1981
- Reduced prostacyclin activity in systemic lupus erythematosus.Annals of the Rheumatic Diseases, 1980
- Monoclonal immunoglobulin M lambda coagulation inhibitor with phospholipid specificity. Mechanism of a lupus anticoagulant.Journal of Clinical Investigation, 1980
- A Sensitive Test Demonstrating Lupus Anticoagulant and its Behavioural PatternsBritish Journal of Haematology, 1978